Asia Pacific Aquaculture Vaccines Market Size & Outlook
Asia Pacific aquaculture vaccines market, 2018-2030 (US$M)
Related Markets
Asia Pacific aquaculture vaccines market highlights
- The Asia Pacific aquaculture vaccines market generated a revenue of USD 91.0 million in 2023.
- The market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 91.0 million |
| Market revenue in 2030 | USD 180.1 million |
| Growth rate | 10.2% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
| Key market players worldwide | Zoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, KBNP, Vaxxinova, HIPRA |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.9% of the global aquaculture vaccines market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 180.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aquaculture Vaccines Market Scope
Aquaculture Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific aquaculture vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aquaculture vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 34.62% in 2023. Horizon Databook has segmented the Asia Pacific aquaculture vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The region leads in the production of several aquatic species such as tilapia. In addition, rising prevalence of bacterial and zoonotic infections among aquaculture population has been observed, which has widened opportunities for preventive measures including vaccination.
Fish farming companies are expected to be the key end users for aquaculture vaccines. A team of researchers at the Institute of Biology of the University of the Philippines developed an oral vaccine for fish with a unique technology for improved delivery.
According to the research team, bacterial infection by Aeromonas species is one of the main causes of mortality in tilapia. However, even though oral vaccination is considered the most suitable to immunize, the degradation of the antigens in the stomach reduces its effectiveness.
Reasons to subscribe to Asia Pacific aquaculture vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific aquaculture vaccines market databook
-
Our clientele includes a mix of aquaculture vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific aquaculture vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific aquaculture vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific aquaculture vaccines market size, by country, 2018-2030 (US$M)
Asia Pacific Aquaculture Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
